Showing results (371-380 of 418) with videos related to

Sort By:
Pageof 42
The New England Journal of Medicine|July 17, 1986
Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamideA M Yeager, H Kaizer, G W Santos, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2019
Reaction of O2 with a diiron protein generates a mixed-valent Fe2+/Fe3+ center and peroxideJustin M Bradley, Dimitri A Svistunenko, Jacob Pullin, et al.
Cancer|April 15, 1990
A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association StudyD R White, B L Powell, J B Craig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2011
A phase I clinical-pharmacodynamic study of the farnesyltransferase inhibitor tipifarnib in combination with the proteasome inhibitor bortezomib in advanced acute leukemiasJeffrey E Lancet, Vu H Duong, Elliott F Winton, et al.
Mbio|June 30, 2016
Light Regimes Shape Utilization of Extracellular Organic C and N in a Cyanobacterial BiofilmRhona K Stuart, Xavier Mayali, Amy A Boaro, et al.
Head & Neck|June 16, 2001
Localized non-Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patientsA A Ezzat, E M Ibrahim, A N El Weshi, et al.
Blood Advances|October 17, 2024
Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapyGeoffrey L Uy, Vinod Pullarkat, Praneeth Baratam, et al.
Breast Cancer Research and Treatment|November 10, 2000
High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatinA A Ezzat, E M Ibrahim, D S Ajarim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 12, 2013
Prediction of poor mobilization of autologous CD34+ cells with growth factor in multiple myeloma patients: implications for risk-stratificationLuciano J Costa, Elizabeth J Nista, Francis K Buadi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 8, 2007
Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancerJ A Meyerhardt, K Stuart, C S Fuchs, et al.
Pageof 42